News
New ESOU Chairman talks about aims & current onco-urology challenges
We interviewed the new Chairman of the EAU Section of Oncological Urology (ESOU), Prof. Morgan Rouprêt (FR), who shared his vision for the ESOU, his insights on the current challenges in onco-urology and the possible breakthroughs in the coming...
EMUC18: Updates on notable trials
Developments of notable trials were announced today during Plenary Session 06 New trials update: What we need to know which was chaired by Dr. Laurence Colette (BE), Dr. Ganesh Palapattu (US), Dr. Stephen Boorjian (US) and Dr. Alberto Bossi (FR). In his...
New EAU Policy Briefing on Kidney Cancer
As one of the most lethal genitourinary cancers, a greater recognition of kidney cancer as a European healthcare problem is a principal requirement. During the Kidney Cancer Europe Roundtable organised by the International Centre for Parliamentary Studies (ICPS), caregivers,...
ESOU19 aims to strengthen onco-urology global community
New technologies and developments in diagnosis, treatment and follow-up in prostate, bladder, renal, testicular and penile cancers are some of the topics to look forward to at the 16th Meeting of the EAU Section of Oncological Urology (ESOU19). The...
ESOU17: “Game changer ahead” in lymph node staging detection
Emerging research presented at ESOU17 showed encouraging results on the use of PSMA-PET for the diagnosis of lymph node staging. However, Prof. Markus Graefen (Hamburg, DE) did start his talk by reminding the audience on day two of ESOU17 that...
ESOU17 Day 1: An interview with the ‘local’ organiser
Prostate cancer was the leading topic in the morning session of the first day of ESOU17, the 14th Meeting of the EAU Section of Oncological Urology. The meeting took place in Barcelona on 20-22 January 2017. Due to a change...
ESOU16, Day 2: Working together and communicating
One of the overarching themes of the second day of ESOU16 was multidisciplinarity. Delegates started the day with the second session devoted to prostate cancer, which is by far the most-covered topic in the three days of the 13th...
ESOU16, Day 1: The role of MRI in PCa diagnosis and active surveillance
Within five years, a standardized technique will be developed for deploying MRI in the diagnosis of prostate cancer. Urologists will be familiar with the PI-RADS (Prostate Imaging Reporting and Data System) scheme, and cooperate closely with better-trained radiologists in...
ESOU16: Highlights from the Scientific Programme
According to local organiser, Prof. Piotr Chlosta (Crakow, PL) ESOU16 will offer the most up-to-date lectures on onco-urology surgery. For its 13th meeting, the EAU Section of Oncological Urology can draw on a wealth of experience in organising cutting-edge...
12th ESOU: Focus on multidisciplinary teamwork and training
Close to 900 urologists, oncologists and other medical specialists gathered in Munich on January 16 to 18 January to discuss how to improve treatment outcomes in urological cancers during the 12th EAU Section of Oncological Urology (ESOU) Meeting. The...
5 years of STEPS: the way forward
2015 marks the 5th anniversary of the successful “Sessions To Evaluate ProgresS in the management of urological cancers” (STEPS). The meetings are chaired by ESOU Chairman, Professor Maurizio Brausi. This innovative partnership between ESOU, IPSEN and the EAU provides...
12th ESOU meeting discusses personalised medicine and the future of onco-urology
Munich welcomed close to 900 delegates to yet another successful edition of the meeting of the EAU Section of Oncological Urology (ESOU), from 16 – 18 January, 2015. The need for collaboration with other medical disciplines to improve outcomes,...